Asthma Education (Respiratory Therapy)
A patient runs five times a week and uses a short-acting beta2 agonist 10 to 15 minutes
before running to prevent EIB. At the patient's next follow-up appointment, what should the RT do? - ANSWEREncourage this practice and check with the patient to be sure that it is effective in controlling asthma symptoms associated with exercise.
A patient arrives at the emergency clinic hyperventilating and complaining of wheezing and feeling tired. The patient states that this is the first episode of breathing distress in over a week and that the shortness of breath has lasted for the past 6 hours. The patient's PaCO2 is normal, although the breathing rate is increased. During the hour before coming to the emergency clinic, the patient used a short-acting beta2 agonist MDI six times without relief. The PEF is 40% of the patient's personal best. What should
the RT do? - ANSWERTreat the patient for severe exacerbation of asthma and impending respiratory failure.
An older adult patient is in the asthma clinic being instructed on a long-acting beta2 agonist MDI. The patient is able to handle the inhaler and actuate it, but there is a lag between actuation and the start of inspiration. What should the RT do? - ANSWERDispense a spacer device to use with the MDI.
During a patient's asthma clinic visit, a spirometry test is performed. The patient's normal FEV1 is 4 L, and the result of the spirometry test is 2.9 L, which is 72.5% of predicted. What is the best interpretation of these measurements? - ANSWERThe findings are consistent with persistent moderate asthma severity.
An adult patient has been hospitalized for an acute asthma exacerbation. The patient is ready to be discharged home. What should the patient's treatment plan include? - ANSWERA long-acting beta2 agonist and an inhaled corticosteroid with a short-acting beta2 agonist, instructions on using a peak flow meter and monitoring peak flow rates, and an asthma action plan
A patient runs five times a week and uses a short-acting beta2 agonist 10 to 15 minutes
before running to prevent EIB. At the patient's next follow-up appointment, what should the RT do? - ANSWEREncourage this practice and check with the patient to be sure that it is effective in controlling asthma symptoms associated with exercise.
A patient arrives at the emergency clinic hyperventilating and complaining of wheezing and feeling tired. The patient states that this is the first episode of breathing distress in over a week and that the shortness of breath has lasted for the past 6 hours. The patient's PaCO2 is normal, although the breathing rate is increased. During the hour before coming to the emergency clinic, the patient used a short-acting beta2 agonist MDI six times without relief. The PEF is 40% of the patient's personal best. What should
the RT do? - ANSWERTreat the patient for severe exacerbation of asthma and impending respiratory failure.
An older adult patient is in the asthma clinic being instructed on a long-acting beta2 agonist MDI. The patient is able to handle the inhaler and actuate it, but there is a lag between actuation and the start of inspiration. What should the RT do? - ANSWERDispense a spacer device to use with the MDI.
During a patient's asthma clinic visit, a spirometry test is performed. The patient's normal FEV1 is 4 L, and the result of the spirometry test is 2.9 L, which is 72.5% of predicted. What is the best interpretation of these measurements? - ANSWERThe findings are consistent with persistent moderate asthma severity.
An adult patient has been hospitalized for an acute asthma exacerbation. The patient is ready to be discharged home. What should the patient's treatment plan include? - ANSWERA long-acting beta2 agonist and an inhaled corticosteroid with a short-acting beta2 agonist, instructions on using a peak flow meter and monitoring peak flow rates, and an asthma action plan